3rd December 2020
Congratulations to Dr Miguel Ganuza from Barts Cancer Institute’s Centre for Haemato-Oncology who is the recipient of a Career Development Award from the Medical Research Council. The award of approximately £1.5 million over 5 years will fund a research project that will investigate how the bone marrow supports blood stem cells and how changes within the bone marrow can drive the development of diseases, such as leukaemia.
Read more3rd June 2020
One of the first studies to investigate the outcome of Covid-19 infection in patients with blood cancer has been conducted by clinical researchers from Barts Cancer Institute, Queen Mary University of London, and Barts Health NHS Trust.
Read more3rd March 2020
Research has identified new genetic features implicated in a type of blood cancer known as familial myeloid leukaemia. The study, published in Nature Communications, offers novel insights into the biology of this inherited cancer, and provides a framework to inform how to more effectively manage at-risk individuals and patients affected by this type of blood malignancy.
Read more19th November 2019
Last month, Barts Cancer Institute’s Dr Bela Wrench hosted a session as part of the Bloodwise Lab Tour Programme, aimed at bringing current and potential supporters closer to research funded by the charity and to demonstrate the impact they can have in the fight against blood cancer.
Read more15th October 2019
We recently spoke with Dr Jessica Okosun about her work as a clinical researcher working on lymphoma. Find out about her motivations for becoming a clinical researcher and her work on blood cancers.
Read more